Cenix BioScience announced this week that it has signed a research agreement with Sygnis Bioscience.
Under the deal, Cenix will develop and optimize multi-parametric microscopy-based assays and conduct target validation studies to identify novel therapeutic drug targets for Sygnis.
Additional terms of the arrangement were not disclosed.